article thumbnail

Innovation in immuno-oncology: Leading companies in in-vitro T-cell activation

Pharmaceutical Technology

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology in Pharmaceuticals: In-vitro T-cell activation. Immatics is the leading patent filer in in-vitro T-cell activation.

In-Vitro 130
article thumbnail

In vitro gametogenesis: the science has to be right, and it has to be safe

pharmaphorum

Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).

In-Vitro 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study: Prednisone does not improve in vitro fertilization outcomes

Medical Xpress

Among patients with recurrent implantation failure during in vitro fertilization, treatment with prednisone does not improve the live birth rate versus placebo, according to a study published in the May 2 issue of the Journal of the American Medical Association (JAMA).

article thumbnail

Skipping Informed Consent for In Vitro Diagnostic (IVD) Trials: Understanding the Exceptions

Cloudbyz

Understanding the exceptions in Informed consent is an essential aspect of ethical clinical research because it concerns full awareness of risks and benefits related to research, as well as procedures. This is particularly relevant for infectious diseases where rapid diagnosis and treatment are important in disease control before its spread.

article thumbnail

A Review Of The Regulatory Landscape for In Vitro Gametogenesis

WCG Clinical

To view it please enter your password below: Password: The post A Review Of The Regulatory Landscape for In Vitro Gametogenesis appeared first on WCG. This content is password protected.

article thumbnail

Positive in vitro results for Imutex’s FLU-v

Pharma Times

Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine

In-Vitro 155
article thumbnail

Latin America In-Vitro Diagnostic Tests Research Report 2021 – ResearchAndMarkets.com

BioTech 365

Latin America In-Vitro Diagnostic Tests Research Report 2021 – ResearchAndMarkets.com Latin America In-Vitro Diagnostic Tests Research Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “The Market for In Vitro Diagnostic Tests in Latin America” report has been added to ResearchAndMarkets.com’s (..)